CenterWatch

Crohn's Disease Clinical Trials

A listing of Crohn's Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

Alabama

Research Site
Additional Locations Alabama

A Multicenter Study to Measure the Transfer of Cimzia® From Women to Infants Via the Placenta (CRIB)

Research Site
Additional Locations Alabama

A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers (CRADLE)

Achieve Clinical Research, LLC an Accel Research Site
Birmingham Alabama 35216

A randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability and efficacy of AMG 181 in subjects with Moderate to Severe Crohn's Disease

View More ▼

UPDATED

Huntsville Alabama 35802

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Mobile Alabama

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Birmingham Alabama 35209

Patients are needed to participate in a clinical research study of Adalimumab to evaluate Crohn's Disease

Dothan Alabama 36305

Patients are needed to participate in a clinical research study of Adalimumab to evaluate Crohn's Disease

Alaska

Research Site
Additional Locations Alaska

A Multicenter Study to Measure the Transfer of Cimzia® From Women to Infants Via the Placenta (CRIB)

Research Site
Additional Locations Alaska

A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers (CRADLE)

Arizona

Research Site
Additional Locations Arizona

A Multicenter Study to Measure the Transfer of Cimzia® From Women to Infants Via the Placenta (CRIB)

Research Site
Additional Locations Arizona

A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers (CRADLE)

View More ▼

UPDATED

Phoenix Arizona

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

UPDATED

Scottsdale Arizona 85260

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85724

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85712

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85741

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Tucson Arizona 85712

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

Scottsdale Arizona

A clinical trial to evaluate the transfer of Certolizumab Pegol into the Breast milk of lactating mothers

Scottsdale Arizona 85260

A Phase 2 clinical study for patients with Crohn's Disease

Scottsdale Arizona 85258

A Phase 2 clinical study for patients with Crohn's Disease

Scottsdale Arizona 85260-1315

Patients are needed to participate in a clinical research study of Natalizumab to evaluate Crohn's Disease

Tucson Arizona 85712

A Phase 2 clinical study for patients with Crohn's Disease

Tucson Arizona 85712

A Phase 2 clinical study for patients with Crohn's Disease

Arkansas

Research Site
Additional Locations Arkansas

A Multicenter Study to Measure the Transfer of Cimzia® From Women to Infants Via the Placenta (CRIB)

Research Site
Additional Locations Arkansas

A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers (CRADLE)

View More ▼

UPDATED

Little Rock Arkansas 72211

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Little Rock Arkansas 72205

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Little Rock Arkansas 72205

A clinical trial to evaluate treatments using RHB-104 and Placebo for patients with Crohn's Disease

UPDATED

North Little Rock Arkansas 72117

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Sherwood Arkansas 72120

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

California

Research Site
Additional Locations California

A Multicenter Study to Measure the Transfer of Cimzia® From Women to Infants Via the Placenta (CRIB)

Research Site
Additional Locations California

A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers (CRADLE)

Precision Research Institute
San Diego California 92114

A phase II, multicenter, randomized, double-blind, multiple dose, placebo-controlled, parallel-group study to evaluate the efficacy, pharmacokinetics, and safety of BI 655066, an IL-23 p19 antagonist monoclonal antibody, in patients with moderately to severely active Crohn’s Disease, who are naïve to, or were previously treated with anti- TNF therapy.

View More ▼

UPDATED

Bakersfield California 93301

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Garden Grove California 92845

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

La Jolla California 92037

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

La Mirada California 90638

A clinical trial to evaluate treatments using RHB-104 and Placebo for patients with Crohn's Disease

UPDATED

La Mirada California 90638

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Laguna Hills California 92653

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Los Angeles California 90067

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Los Angeles California

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

UPDATED

Los Angeles California 90045

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Mission Hills California 91345

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Northridge California 91324

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Oakland California

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

UPDATED

Oceanside California 92056

Patients are needed to participate in a clinical research study evaluating Rifaximin Delayed Response (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Orange California 92868

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

UPDATED

Sacramento California 95825

A clinical trial to evaluate treatments using RHB-104 and Placebo for patients with Crohn's Disease